newsfilter
← Latest News
FDA Approved Drugs·

Approval of Danyelza, Bla #761171

Approval Date: 08/27/2025; Drug Name: Danyelza, Bla #761171; Active Ingredients: NAXITAMAB-GQGK; Company: Y-mabs Therapeutics Inc; Submission Status: Approval; Application Number: 761171

Company
Y-MABS THERAPEUTICS INC
Keywords
Y-MABS THERAPEUTICS INC